Menu
Not yet recruiting NCT07416617

Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction

Observational Acute Myocardial Infarction Insomina

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Insomnia medication, No insomnia medication.
Who it may be relevant to
Registry conditions: Acute Myocardial Infarction, Insomina. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.

Interventions

  • Drug Insomnia medication
    Diagnosed as insomnia and use of anti-insomnia medication
  • Other No insomnia medication
    Diagnosed as insomnia and did not use of anti-insomnia medication

Primary outcome measures

  • Rates of MACCE [Time frame: up to 10 years]
Secondary outcome measures (4)
  • Rates of Death [Time frame: up to 10 years]
  • Rates of Revascularization [Time frame: up to 10 years]
  • Rates of Spontaneous MI [Time frame: up to 10 years]
  • Rates of Ischemic stroke [Time frame: up to 10 years]

Eligibility criteria

Inclusion criteria

  • Diagnosis of acute myocardial infarction
  • Undergoing percutaneous coronary intervention or coronary artery bypass surgery

Exclusion criteria

  • Pre-existing phychiatric disorders

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

South Korea · 1 center
  • Samsung Medical Center — Seoul

Identifiers

NCT: NCT07416617 · MI_Insomnia

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗